Aminocaproic acid

Also known as: 6-aminohexanoic acid ε-Ahx ε-aminocaproic acid

Active ingredient description

Aminocaproic acid is 6-aminohexanoic acid, which acts as an inhibitor of fibrinolysis. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Aminocaproic acid
B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AA Amino acids
Discover more medicines within B02AA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Structured Product Labeling (SPL)

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₆H₁₃NO₂
Molecular mass: 131.173 g/mol

External identifiers

CAS Substance: 60-32-2
DrugBank Drug: DB00513
KEGG Drug: D00160
PubChem Compound: 564
RxNorm Ingredient: 99
SNOMED-CT Concept: 59882007
Aminocaproic acid (substance)
UNII Identifier: U6F3787206


Aminocaproic acid is an active ingredient of these brands:

United States (US)

Brazil (BR)

Ecuador (EC)

Hong Kong (HK)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.